Gene First Approach to Connective Tissue Disease
NCT04664478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2025-09-04
Summary
Background:
Elastic fibers affect parts of the body that stretch repetitively, such as the skin, blood vessels, and lungs. Researchers want to use medical and research tests in patients with already identified changes in a set of connective tissue genes to better understand diseases related to elastic fibers.
Objective:
To learn more about the impact of underlying changes in a set of connective tissue genes on people s overall health.
Eligibility:
People ages 2-100 who have had a gene test that identified a change in a gene that affects elastic fibers. Initial emphasis will be placed on people with changes in ELN, LOX, MFAP4, FBLN5 and EFEMP2.
Design:
Participants will visit the NIH for several days to perform tests that will help researchers learn more about how changes in connective tissue genes affect a person s health. They will also have clinicians take their medical history and physical exam. Optional tests include giving blood samples, hair strand, urine, and/or saliva samples. They may have a cheek swab or skin biopsy. Their genes may be studied. Their cells may be grown in a laboratory. Participants may have photographs taken of the face and body.
They will receive exams by a medical team with experience in connective tissue disease. They may have a dental exam or eye exams and with photography. During the eye exam, pictures may be taken of the blood vessels in the eyes. If this occurs, they will get dye through an intravenous (IV) line in an arm vein.
They will also have medical tests to check the health of tissues that may be affected by these connective tissue genes. Participants may have lung function tests. They may have a six-minute walk test. They may complete a treadmill or bike stress test. Their heart s electrical activity may be recorded. Participants may have X-rays and ultrasounds. They may have a DEXA scan to measure bone density. They may have CT, MRI or other imaging scans. Some of these tests require the participant to get a contrast fluid via IV.
Participants may have a skin elasticity test using a suction cup that pulls lightly on their skin.
Participants may wear blood pressure cuffs while probes are placed on their skin. The tests will be chosen for each individual based on their specific gene change and no person is expected to complete all tests. Participation will last 3-5 days.
Conditions
- Abnormal Elastogenesis
- Vascular Diseases
- Connective Tissue Diseases
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Manfred Boehm, M.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 2 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-22
- Primary Completion
- 2025-08-29
- Completion
- 2025-08-29
Countries
- United States
Study Locations
More Related Trials
-
Natural History Study for DNA Repair Disorders
NCT05484570 ·Status: RECRUITING
-
CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium
NCT01808729 ·Status: COMPLETED
-
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
NCT01387035 ·Status: RECRUITING
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Study and Treatment of Inflammatory Muscle Diseases
NCT00001265 ·Status: COMPLETED
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572 ·Status: TERMINATED
-
Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
NCT02680431 ·Status: UNKNOWN
-
Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
NCT00895271 ·Status: ENROLLING_BY_INVITATION
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Defining the Basis of Fibromuscular Dysplasia (FMD)
NCT01967511 ·Status: RECRUITING
-
Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease
NCT06325488 ·Status: RECRUITING
-
Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
NCT01768026 ·Status: WITHDRAWN
-
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
NCT06976073 ·Status: RECRUITING
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
NCT04959188 ·Status: COMPLETED
-
Study of Silicone-Associated Connective Tissue Diseases
NCT00001330 ·Status: COMPLETED
-
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479 ·Status: COMPLETED
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
NCT06602232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients
NCT01446783 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
NCT00946699 ·Status: COMPLETED ·Phase: PHASE1
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING